arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2511.05967cs.CVcs.AI
收藏

适配的基础模型用于增强和非增强方案下的乳腺MRI分诊

Adapted Foundation Models for Breast MRI Triaging in Contrast-Enhanced and Non-Contrast Enhanced Protocols

Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)(弗里德里希-亚历山大大学埃尔兰根-纽伦堡分校);Uniklinikum Erlangen(埃尔兰根大学医院);Radiology München(慕尼黑放射科);Polish Academy of Science(波兰科学院)
Tri-Thien Nguyen, Lorenz A. Kapsner, Tobias Hepp, Shirin Heidarikahkesh, Hannes Schreiter, Luise Brock, Dominika Skwierawska, Dominique Hadler, Julian Hossbach,… 展开作者

Tri-Thien Nguyen, Lorenz A. Kapsner, Tobias Hepp, Shirin Heidarikahkesh, Hannes Schreiter, Luise Brock, Dominika Skwierawska, Dominique Hadler, Julian Hossbach, Evelyn Wenkel, Sabine Ohlmeyer, Frederik B. Laun, Andrzej Liebert, Andreas Maier, Michael Uder, Sebastian Bickelhaupt

AI总结:

本研究提出基于DINOv2的医学切片Transformer框架,用于增强和非增强简化乳腺MRI的病变分诊,在高灵敏度下实现一定特异度,外部验证表现稳定,为AI辅助乳腺MRI预筛查提供支持。

摘要:

研究背景:磁共振成像(MRI)对乳腺癌检测具有高灵敏度,但解读耗时,人工智能或可辅助预筛查。研究目的:评估基于DINOv2的医学切片Transformer(Medical Slice Transformer,MST)在增强和非增强简化乳腺MRI中排除显著病变(乳腺影像报告和数据系统[BI-RADS]≥4级)的性能。材料与方法:本项经机构审查委员会批准的回顾性研究纳入内部数据集的1847次单侧乳腺MRI检查(其中377次BI-RADS≥4级),以及外部验证数据集(Duke)的924次检查。测试了四种简化方案:T1加权早期减影(T1sub)、b值为1500 s/mm²的弥散加权成像(DWI1500)、DWI1500联合T2加权(T2w)、T1sub联合T2w。采用五折交叉验证和受试者工作特征曲线下面积(AUC)分析,在90%、95%和97.5%的灵敏度水平下评估性能,通过DeLong检验比较AUC差异。在外部数据集中对假阴性病例进行特征分析,并对真阳性病例的注意力图进行评级。研究结果:共纳入1448名女性患者(平均年龄49±12岁)。T1sub+T2w方案的AUC为0.77±0.04,DWI1500+T2w方案为0.74±0.04(p=0.15)。在97.5%灵敏度下,T1sub+T2w的特异度最高(19%±7%),其次是DWI1500+T2w(17%±11%)。在95%和97.5%的阈值下,T1sub和DWI1500方案漏诊的病灶平均直径均小于10 mm,以非肿块样强化为主。外部验证的AUC为0.77,88%的注意力图被评为良好或中等。研究结论:在97.5%的灵敏度下,MST框架可正确分诊无BI-RADS≥4级病变的病例,增强MRI的特异度达19%,非增强MRI达17%,临床应用前仍需进一步研究。

英文摘要:

Background: Magnetic resonance imaging (MRI) has high sensitivity for breast cancer detection, but interpretation is time-consuming. Artificial intelligence may aid in pre-screening. Purpose: To evaluate the DINOv2-based Medical Slice Transformer (MST) for ruling out significant findings (Breast Imaging Reporting and Data System [BI-RADS] >=4) in contrast-enhanced and non-contrast-enhanced abbreviated breast MRI. Materials and Methods: This institutional review board approved retrospective study included 1,847 single-breast MRI examinations (377 BI-RADS >=4) from an in-house dataset and 924 from an external validation dataset (Duke). Four abbreviated protocols were tested: T1-weighted early subtraction (T1sub), diffusion-weighted imaging with b=1500 s/mm2 (DWI1500), DWI1500+T2-weighted (T2w), and T1sub+T2w. Performance was assessed at 90%, 95%, and 97.5% sensitivity using five-fold cross-validation and area under the receiver operating characteristic curve (AUC) analysis. AUC differences were compared with the DeLong test. False negatives were characterized, and attention maps of true positives were rated in the external dataset. Results: A total of 1,448 female patients (mean age, 49 +/- 12 years) were included. T1sub+T2w achieved an AUC of 0.77 +/- 0.04; DWI1500+T2w, 0.74 +/- 0.04 (p=0.15). At 97.5% sensitivity, T1sub+T2w had the highest specificity (19% +/- 7%), followed by DWI1500+T2w (17% +/- 11%). Missed lesions had a mean diameter <10 mm at 95% and 97.5% thresholds for both T1sub and DWI1500, predominantly non-mass enhancements. External validation yielded an AUC of 0.77, with 88% of attention maps rated good or moderate. Conclusion: At 97.5% sensitivity, the MST framework correctly triaged cases without BI-RADS >=4, achieving 19% specificity for contrast-enhanced and 17% for non-contrast-enhanced MRI. Further research is warranted before clinical implementation.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑